Literature DB >> 27940785

School-Located Influenza Vaccinations: A Randomized Trial.

Peter G Szilagyi1, Stanley Schaffer2, Cynthia M Rand2, Phyllis Vincelli2, Ashley Eagan2, Nicolas P N Goldstein2, A Dirk Hightower3, Mary Younge4, Aaron Blumkin2, Christina S Albertin5, Byung-Kwang Yoo6, Sharon G Humiston7.   

Abstract

OBJECTIVE: Assess impact of offering school-located influenza vaccination (SLIV) clinics using both Web-based and paper consent upon overall influenza vaccination rates among elementary school children.
METHODS: We conducted a cluster-randomized trial (stratified by suburban/urban districts) in upstate New York in 2014-2015. We randomized 44 elementary schools, selected similar pairs of schools within districts, and allocated schools to SLIV versus usual care (control). Parents of children at SLIV schools were sent information and vaccination consent forms via e-mail, backpack fliers, or both (depending on school preferences) regarding school vaccine clinics. Health department nurses conducted vaccine clinics and billed insurers. For all children registered at SLIV/control schools, we compared receipt of influenza vaccination anywhere (primary outcome).
RESULTS: The 44 schools served 19 776 eligible children in 2014-2015. Children in SLIV schools had higher influenza vaccination rates than children in control schools county-wide (54.1% vs 47.4%, P < .001) and in suburban (61.9% vs 53.6%, P < .001) and urban schools (43.9% vs 39.2%; P < .001). Multivariate analyses (controlling for age, grade, vaccination in previous season) confirmed bivariate findings. Among parents who consented for SLIV, nearly half of those notified by backpack fliers and four-fifths of those notified by e-mail consented online. In suburban districts, SLIV did not substitute for primary care influenza vaccination. In urban schools, some substitution occurred.
CONCLUSIONS: SLIV raised seasonal influenza vaccination rates county-wide and in both suburban and urban settings. SLIV did not substitute for primary care vaccinations in suburban settings where pediatricians often preorder influenza vaccine but did substitute somewhat in urban settings.
Copyright © 2016 by the American Academy of Pediatrics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27940785     DOI: 10.1542/peds.2016-1746

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

1.  Addressing barriers to vaccine acceptance: an overview.

Authors:  Noni E MacDonald; Robb Butler; Eve Dubé
Journal:  Hum Vaccin Immunother       Date:  2017-11-29       Impact factor: 3.452

2.  Factors associated with childhood influenza vaccination in Israel: a cross-sectional evaluation.

Authors:  Aharona Glatman-Freedman; Kanar Amir; Rita Dichtiar; Hila Zadka; Ifat Vainer; Dolev Karolinsky; Teena Enav; Tamy Shohat
Journal:  Isr J Health Policy Res       Date:  2019-11-26

3.  City-wide school-located influenza vaccination: A retrospective cohort study.

Authors:  Jade Benjamin-Chung; Benjamin F Arnold; Kunal Mishra; Chris J Kennedy; Anna Nguyen; Nolan N Pokpongkiat; Stephanie Djajadi; Anmol Seth; Nicola P Klein; Alan E Hubbard; Arthur Reingold; John M Colford
Journal:  Vaccine       Date:  2021-09-14       Impact factor: 3.641

4.  Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany.

Authors:  Daniel Molnar; Anastassia Anastassopoulou; Barbara Poulsen Nautrup; Ruprecht Schmidt-Ott; Martin Eichner; Markus Schwehm; Gael Dos Santos; Bernhard Ultsch; Rafik Bekkat-Berkani; Alfred von Krempelhuber; Ilse Van Vlaenderen; Laure-Anne Van Bellinghen
Journal:  Hum Vaccin Immunother       Date:  2022-04-29       Impact factor: 4.526

5.  Evaluation of a city-wide school-located influenza vaccination program in Oakland, California with respect to race and ethnicity: A matched cohort study.

Authors:  Anna T Nguyen; Benjamin F Arnold; Chris J Kennedy; Kunal Mishra; Nolan N Pokpongkiat; Anmol Seth; Stephanie Djajadi; Kate Holbrook; Erica Pan; Pam D Kirley; Tanya Libby; Alan E Hubbard; Arthur Reingold; John M Colford; Jade Benjamin-Chung
Journal:  Vaccine       Date:  2021-12-03       Impact factor: 3.641

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.